NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research

        • Research Overview
        • Clinical Research Facility
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient & Public Involvement
    • Getting involved with research
    • View and register for involvement opportunities
    • Patient & Public Groups
    • Patient and Public Involvement Advisory Group
    • Diversity in Research Group
    • Oxford Blood Group
    • Case Studies
    • PPIE Strategy
    • PPIE News
    • PPI Researcher Guidance
    • Researchers: Post a PPIE opportunity
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > COVID-19 > Study highlights role of BMI in increased COVID-19 risks

Study highlights role of BMI in increased COVID-19 risks

29 April 2021 · Listed under COVID-19, Obesity, Diet and Lifestyle, Translational Data Science

A study by University of Oxford researchers has found that the risk of admission to hospital, admission to ICU or death from COVID-19 increases progressively above a ‘normal’ BMI of 23, even without other comorbidities.

Photo by i yunmai on Unsplash

The research team, who are supported by the NIHR Oxford Biomedical Research Centre (BRC), found that BMI is a greater risk factor for people aged 20 to 39 years than for older people, and for black people than for white people.

The study, published in The Lancet Diabetes and Endocrinology, looked at the anonymous health records from almost 7 million people in England aged between 20 and 99 years.

It found that the lowest risk was among those with a BMI of 23 kg/m2, at which point the risk increased linearly, around 5% higher risk of hospital admission, 10% higher risk of ICU admission, and 4% of death per unit increase in BMI.

Notably, the effect of excess weight on the risk of severe COVID was greatest in young people aged 20 to 39 years of age, and decreased after the age of 60. Excess weight had very little effect on the risk of severe COVID in people aged over 80 years.

The risks associated with higher BMI were greater for black people than white people. The increase in the risk of hospitalisation per BMI unit for black people was 7% compared with 4% for white people. And the increase in the risk of death for black people was 8% versus 4% for white people. There was no evidence that the risks for other ethnic groups differed from those of the white populations.

As the team say in the paper: “Excess weight is a modifiable risk factor and investment in the treatment of overweight and obesity and long-term preventive strategies could help reduce the severity of COVID-19 disease.”

The analysis took into account several factors that might influence risk, such as age, sex, ethnicity and existing health conditions, including type 2 diabetes. People with a BMI under 23, including those who are underweight (a BMI below 18.5) were also at risk of COVID-related hospital admission and death.

Read an article in The Conversation about this study.

← Azithromycin not effective against COVID-19, trial confirms
Foods linked to greater risk of cardiovascular disease and death in middle-age identified →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre